Discover the transformative potential of the Illumina TruSight Oncology 500 (TSO500) assay in global clinical trials. Our on-demand virtual Lunch and Learn session, hosted by GenomeWeb, features a comprehensive presentation by Jennifer Sims, Director of Genomics Assay Development at IQVIA Laboratories.
Session Highlights:
Expert Presenter:
Jennifer Sims, Director of Genomics Assay Development at IQVIA Laboratories, brings her extensive expertise to the forefront, sharing invaluable insights into the implementation of the TSO500 assay.
Real-World Experience:
Gain knowledge from real-world applications across multiple international sites, providing you with a practical understanding of implementing the TSO500 assay in diverse environments.
Key Topics Covered:
Overcoming Operational Challenges: Learn strategies to tackle logistical and operational hurdles in deploying the TSO500 assay across global clinical trials.
Data Harmonization: Understand how to achieve data consistency and reliability across different laboratories and regions.
Quality Control Across Laboratories: Discover best practices for maintaining high-quality standards and consistency in genomic data collection and analysis.
Navigating Regulatory Requirements: Explore the complexities of regulatory landscapes across various regions and how to meet compliance standards effectively.
Why Attend? This session is designed for professionals in the genomics and clinical trials fields who are keen to enhance their understanding of the TSO500 assay and its application in global settings. Whether you're facing operational, data, or regulatory challenges, this presentation offers actionable insights to optimize your clinical trial processes.
Watch Now: Access this insightful session at your convenience. Simply click the button below to begin your on-demand learning experience.
Speaker:
Jennifer Sims, PhD
Director, Genomics Assay Development, IQVIA Laboratories
Jennifer Sims is the director of genomics assay development at IQVIA Laboratories. In this role, she is responsible for the oversight of a team of scientists who develop and validate genomic assays to support clinical trials. This includes broad-based screening assays, such as exome and RNA sequencing, as well as highly focused expression, genotyping, copy number, and sequencing assay panels that target a smaller number of genes.
Sims’ scientific expertise spans immuno-oncology, epigenetics, and cancer biology. She holds a Bachelor of Science degree in biology from the University of North Carolina at Chapel Hill and earned her doctorate in biochemistry and molecular biology from the University of Southern California. She subsequently completed postdoctoral training in the Laboratory of Molecular Carcinogenesis at the National Institute of Environmental Health Sciences
Related Insights
Reproducibility Challenges in an era of Massive Data
Presented at the MCBIOS & MAQC 2021 Joint Conference
A Verified Genomic Reference Sample for Assessing Performance of Cancer Panels Detecting Small Variants of Low Allele Frequency
Presented at the MCBIOS & MAQC 2021 Joint Conference
Unexpected Impacts to Library Complexity After DNA and RNA Library Preparation in Illumina Next Generation Sequencing
Presented at the MCBIOS & MAQC 2021 Joint Conference
Immune Landscape Signatures for Characterization of Tumor Microenvironment and Response to Therapy
Gene expression and analysis for detection of 38 Immune Landscape Signatures
Using Gene Signature Methodologies to Strengthen Immuno-Oncology Trials
Genomic technologies that empower and enhance immuno-oncology trials
Laboratory Solutions for Hepatitis B (HBV) Clinical Trials
Insight brief by Joseph Sebastian, Ph.D., Scientific Advisor, Infectious & Liver Diseases
Enabling blood sample prep for single cell sequencing in clinical research
The Role of Genomics in Clinical Trials with Patrick Hurban
I-O clinical development podcast series
IQVIA Laboratories Corporate Brochure
A global drug discovery and development laboratory services organization
Evaluating and Implementing SARS-CoV-2 PCR Tests for Diagnostic and Clinical Trial Use
AAPS 2020 COVID-19 Workshop: Current Pharmaceutical Developments for Cures and Prevention
